Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Banffy

Sports Medicine Los Angeles, CA Medical Doctor

NPI 1558497982 CMS profile 521384

6801 Park Ter Ste 400, Los Angeles, CA 90045

Open in the dashboard

General payments

$577,711

609 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Banffy of Los Angeles, CA is reported in the CMS Open Payments database as having received $577,711 across 609 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Sports Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $150,555 110
2024 General $69,390 86
2023 General $66,324 82
2022 General $60,928 74
2021 General $118,664 113
2020 General $61,677 62
2019 General $50,172 82

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Banffy
  • Sports Medicine median
  • Middle half of Sports Medicine
  • National median

In program year 2025, general payments to Michael Banffy were reported at $150,555. Among 2,404 Sports Medicine profiles paid that year, the median was $664 and the middle half received between $172 and $3,055.

Show as a table
Year Michael Banffy Sports Medicine median Middle half National median
2019 $50,172 $1,176 $199–$4,249 $163
2020 $61,677 $708 $96–$2,890 $114
2021 $118,664 $1,213 $152–$3,994 $132
2022 $60,928 $1,230 $159–$3,998 $149
2023 $66,324 $584 $146–$2,836 $160
2024 $69,390 $628 $163–$3,168 $164
2025 $150,555 $664 $172–$3,055 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $326,865 351 payments
  2. Stryker Corporation $138,258 128 payments
  3. Vericel Corporation $91,585 71 payments
  4. Arthrex, Inc. $10,062 18 payments
  5. Micromed Inc $5,192 6 payments
  6. Saxum Surgical, Inc. $4,154 13 payments
  7. Linvatec Corporation $555 7 payments
  8. DePuy Synthes Sales Inc. $471 6 payments
  9. Ossur Americas., Inc $142 1 payment
  10. CONMED Corporation $126 1 payment
  11. Other $302 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $321,531 122 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $102,159 29 payments
  3. Travel and Lodging $62,011 98 payments
  4. Food and Beverage $25,023 330 payments
  5. Honoraria $22,800 13 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $20,900 8 payments
  7. Royalty or License $13,687 1 payment
  8. Education $9,600 8 payments
Products named General payments · program years 2019–2025
  1. MACI $57,712 40 payments
  2. SPATIAL FRAME $42,926 20 payments
  3. HEALICOIL Sports Med Shoulder $42,004 15 payments
  4. Bone Anchors with Arthroscopic Delivery System $34,305 17 payments
  5. CAP-FIX $34,174 28 payments
  6. FAST-FIX $29,230 19 payments
  7. NovoStitch $28,282 26 payments
  8. HIPMAP $26,680 9 payments
  9. Q-FIX $26,211 8 payments
  10. HEALICOIL Sports Med Shoulder $25,212 10 payments
  11. Other $410,213 589 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$37,286

Of which drugs: $11,223

Medicare patients

73

Average age 70

Services billed

256

45 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 53%
Ischemic heart disease 23%
Depression 23%
Diabetes 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

609 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sports Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record